S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

NACompletedINTERVENTIONAL
Enrollment

658

Participants

Timeline

Start Date

November 25, 2011

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Bladder Cancer
Interventions
PROCEDURE

therapeutic conventional surgery

Patients undergo radical cystectomy

PROCEDURE

therapeutic standard lymphadenectomy

Patients undergo standard pelvic lymphadenectomy.

PROCEDURE

therapeutic extended lymphadenectomy

Patients undergo extended pelvic lymphadenectomy

Trial Locations (35)

10065

Memorial Sloan-Kettering Cancer Center, New York

14642

University of Rochester, Rochester

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

33612

Moffitt Cancer Center, Tampa

43210

Ohio State University Comprehensive Cancer Center, Columbus

44195

Cleveland Clinic Foundation, Cleveland

55905

Mayo Clinic, Rochester

60153

Loyola University Medical Center, Maywood

60637

University of Chicago Comprehensive Cancer Center, Chicago

63110

Washington University School of Medicine, St Louis

71103

Louisiana State University Health Sciences Center Shreveport, Shreveport

75235

Parkland Memorial Hospital, Dallas

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

77030

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

Baylor Saint Luke's Medical Center, Houston

M D Anderson Cancer Center, Houston

78209

Audie L Murphy Veterans Affairs Hospital, San Antonio

78229

University of Texas Health Science Center at San Antonio, San Antonio

80045

University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora

90033

Los Angeles County-USC Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

94115

UCSF Medical Center-Mount Zion, San Francisco

94158

UCSF Medical Center-Mission Bay, San Francisco

94304

Stanford Cancer Institute, Palo Alto

95817

University of California Davis Comprehensive Cancer Center, Sacramento

97239

Oregon Health and Science University, Portland

Portland Veterans Administration Medical Center, Portland

06520

Yale University, New Haven

02115

Brigham and Women's Hospital, Boston

V5Z 4E6

BCCA-Vancouver Cancer Centre, Vancouver

B3H 1V8

QEII Health Sciences Centre/Capital District Health Authority, Halifax

N6A 4L6

London Regional Cancer Program, London

M5G 2M9

University Health Network-Princess Margaret Hospital, Toronto

H2W 1S6

McGill University Department of Oncology, Montreal

H3H 2R9

The Research Institute of the McGill University Health Centre (MUHC), Montreal

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT01224665 - S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter